The Reading Hospital and Medical Center

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, The Reading Hospital and Medical Center sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 1 currently recruiting 4 completed later-stage tilt upper quartile by trial count

The Reading Hospital and Medical Center: 7 sponsored US clinical trials, 1 recruiting.

The Reading Hospital and Medical Center sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Murmur, with 1 trials.

Upper-quartile sponsor footprint

The Reading Hospital and Medical Center sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Where The Reading Hospital and Medical Center enrollment is open (later-stage tilt)

1 recruiting of 7 indexed (14% open); 4 completed (57%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Heart Murmur (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

The Reading Hospital and Medical Center: open-pipeline peers nationwide

Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

The Reading Hospital and Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40% Total trials Recruiting share The Reading Hospital and Medical Center3M4Life Research89bioAbbott Diagnostics DivisionAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
The Reading Hospital and Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The Reading Hospital and Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this The Reading Hospital and Medical Center page

7 registered trials is a research-attention snapshot, not an endorsement of The Reading Hospital and Medical Center or any single study.

  • 1 of The Reading Hospital and Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Murmur is the condition The Reading Hospital and Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Murmur trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

The Reading Hospital and Medical Center pipeline card: 7 registered trials from official public datasets.Report a data error.